A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘APRAISAL’ study

Background Real‐world data in patients with moderate psoriasis treated with apremilast is limited. Objectives To evaluate the effectiveness and safety of apremilast in bio‐naïve patients with moderate psoriasis in real‐world clinical settings. Methods This was a 52‐week multicenter, observational, p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2022-11, Vol.36 (11), p.2055-2063
Hauptverfasser: Ioannides, D., Antonakopoulos, N., Chasapi, V., Oikonomou, C., Tampouratzi, E., Lazaridou, E., Rigopoulos, D., Neofotistou, O., Drosos, A., Anastasiadis, G., Rovithi, E., Kalinou, C., Papadavid, E., Aronis, P., Papageorgiou, M., Protopapa, A., Bassukas, I., Lefaki, I., Zafiriou, E., Krasagakis, K., Pokas, E., Anagnostopoulos, Z., Kekki, A., Papakonstantis, M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Real‐world data in patients with moderate psoriasis treated with apremilast is limited. Objectives To evaluate the effectiveness and safety of apremilast in bio‐naïve patients with moderate psoriasis in real‐world clinical settings. Methods This was a 52‐week multicenter, observational, prospective study of adult outpatients with moderate psoriasis {[10% 
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.18166